earnings
NASDAQ · LXRX
Lexicon Pharmaceuticals, Inc.
Healthcare · Biotechnology
$2.05
Down-$0.03 (-1.26%)
Updated Sep 21, 2026, 3:03 PM
SID Score
4.9/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 481.5M
- P/E ratio
- -3.99
- Dividend yield
- 0.00%
- 52-week range
- $1.49 – $2.68
- Volume
- 7.46M
- Avg. volume
- 2.31M
Price performance
LXRX price history
1M range · 19 trading sessions · Daily adjusted prices
LXRX closed at $2.05 after 19 trading sessions, down 11.64% for the selected period.
- Last close
- $2.05
- Period change
- -11.64%
- Period low
- $1.98
- Period high
- $2.34
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 18, 2026 | $2.04 | $2.06 | $1.99 | $2.05 | 7.46M |
| Sep 17, 2026 | $2.05 | $2.11 | $2.015 | $2.035 | 2.24M |
| Sep 16, 2026 | $2.01 | $2.055 | $2.00 | $2.02 | 2.15M |
| Sep 15, 2026 | $1.98 | $2.02 | $1.885 | $2.01 | 2.51M |
| Sep 14, 2026 | $1.97 | $2.01 | $1.935 | $1.98 | 1.77M |
| Sep 11, 2026 | $2.05 | $2.06 | $1.95 | $2.00 | 3.73M |
| Sep 10, 2026 | $2.11 | $2.14 | $2.01 | $2.02 | 2.94M |
| Sep 9, 2026 | $2.21 | $2.23 | $2.13 | $2.15 | 2.2M |
| Sep 8, 2026 | $2.22 | $2.25 | $2.19 | $2.23 | 1.66M |
| Sep 4, 2026 | $2.25 | $2.255 | $2.215 | $2.24 | 1.04M |
| Sep 3, 2026 | $2.25 | $2.27 | $2.23 | $2.26 | 1.51M |
| Sep 2, 2026 | $2.21 | $2.265 | $2.19 | $2.24 | 2.34M |
| Sep 1, 2026 | $2.24 | $2.2689 | $2.17 | $2.19 | 1.99M |
| Aug 31, 2026 | $2.27 | $2.29 | $2.19 | $2.25 | 6.65M |
| Aug 28, 2026 | $2.30 | $2.32 | $2.26 | $2.29 | 2.68M |
| Aug 27, 2026 | $2.30 | $2.339 | $2.295 | $2.32 | 1.62M |
| Aug 26, 2026 | $2.32 | $2.3488 | $2.28 | $2.31 | 1.2M |
| Aug 25, 2026 | $2.35 | $2.365 | $2.30 | $2.34 | 1.82M |
| Aug 24, 2026 | $2.32 | $2.35 | $2.295 | $2.32 | 1.68M |
Latest LXRX news
The latest Smart Investors Daily articles mentioning LXRX.
Stock researchCompany · Overview
Loading stock research…